- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2020-000142-34.
Displaying page 1 of 1.
EudraCT Number: 2020-000142-34 | Sponsor Protocol Number: ITCC-092/IST11028 | Start Date*: 2020-09-15 | ||||||||||||||||
Sponsor Name:Princess Máxima Center for pediatric oncology | ||||||||||||||||||
Full Title: A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML, ITCC-092 | ||||||||||||||||||
Medical condition: Relapsed or refractory pediatric acute myeloid leukemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) AT (Ongoing) DK (Ongoing) IT (Ongoing) DE (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
